4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000071
Chief Operating Officer sold 11,551 shares at $17.55 ($202,720)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-27 | Sale : show line 1 in the form 10b5-1 | −11,551 | $17.55 | $202,720 | 215,253 | D |
| Open-market sales · 11,551 sh · avg $17.55 · $202,720 | ||||||
Loading xslF345X05/wk-form4_1711743618.xml…